Toggle Mobile Navigation

Archive for the ‘ExL Events News’ Category

Page 1 of 212

Just Announced: The First and Only Life Science Investor Relations Forum

BrochureExL Events has just announced the industry’s first annual Life Science Investor Relations Forum, hosted on September 7–8, 2017 in Boston, MA. This inaugural event will bring together investor relations professionals to address the diverse set of challenges faced in the life science industry. We’ve assembled an expert speaking faculty who will provide two content-packed days of thought-provoking dialogue. This engaging and informative event will also offer ample networking time for IR professionals.

“We’re excited about this conference. We’ve had professionals tell…

READ MORE


Pfizer Executive Previews the 8th Clinical Quality Oversight Forum in New Interview

One of our esteemed faculty speakers recently sat down with AppliedClinicalTrialsOnline.com to discuss clinical trial quality events, which of course led to some greatly appreciated ExL conference previews! The subject of this interview is Dr. Jonathan Rowe, Executive Director and Head of Clinical Development Quality Performance and Risk Management, at Pfizer. Jonathan is speaking at our 8th Clinical Quality Oversight Forum and touches on his upcoming session in the interview.

Rowe, who recently spoke at ExL’s CROWN Congress, also answers questions regarding Pfizer’s tactics for managing clinical trial…

READ MORE


13th Pharmaceutical Meeting Professionals Summit to Be Held November 6–7, 2017 at the Hilton Philadelphia at Penn’s Landing

The 13th Pharmaceutical Meeting Professionals Summit will be held on November 6–7, 2017 at the Hilton Philadelphia at Penn’s Landing. This interactive summit attracts 200+ senior-level meeting professionals working in the pharmaceutical, biotechnology, and medical device industries, and acts as their annual gathering to learn, engage, and network.

With well over 60% of the 2016 audience representing meeting planners and with 57% of them having more than 10 years of experience in the events industry, this is the ideal forum to learn from and meet with industry veterans to understand current trends, innovation and efficient strategies for optimizing medical meeting…

READ MORE


The Benefits of Clinical Trials for Cancer Patients, According to a Survivor

Twelve years after T.J. Sharpe’s successful melanoma surgery, the husband and father-of-two saw the return of his skin cancer. Faced once again with the unexpected realization of mortality after more than a decade of remission, a clinical trial helped ensure Sharpe would see his children grow up. This patient and survivor is helping spread the word about clinical trials, and how they should be an available option for others like him.

The return of Sharpe’s melanoma was accompanied by a predicted life expectancy of less than two years. He was adamant on…

READ MORE


ExL Partners with the Medical Affairs Professional Society (MAPS)!

ExL Events is excited to announce that we’ve been selected as the exclusive conference partner on a series of promotional, event service, and content exchange with the Medical Affairs Professional Society (MAPS)! While MAPS is a relatively new association, it has proved itself as one of the most formidable organizations in the medical affairs segment. MAPS has been impressing the ExL team since we started covering it in the early 2000s. Find out more about our new partner below!

ExL Events’ co-founder and COO, Ethan Denkensohn, had this to say about the exciting…

READ MORE


Senate Confirms New Head of FDA: Two-Time ExL Speaker Dr. Scott Gottlieb

ExL Events would like to congratulate our speaker alumnus Dr. Scott Gottlieb for the recent United States Senate confirmation, naming him the new Food and Drug Administration commissioner. Dr. Gottlieb was the keynote speaker at ExL’s 2nd Trial Design Innovation Conference and was also a featured speaker at our Private Fee-for-Service event.

President Donald Trump nominated Gottlieb earlier this year, for his previous service as deputy commissioner for the FDA, as well as his experience in the pharmaceutical and health care industries. As the FDA’s newly appointed commissioner, Gottlieb will…

READ MORE


Questex Acquires ExL Events

Acquisition of Leading Life Sciences Event Company Expands Company’s Services in Pharmaceutical, Life Science and Healthcare Markets
Questex logo square
Questex, a leading global business information and events company, today announced it has acquired ExL Events, Inc., expanding Questex’s presence in the global pharmaceutical, life science and healthcare markets.

ExL Events, founded in 2004 as ExL Pharma, is the industry leader in developing innovative, educational conferences that serve the pharmaceutical, life science and healthcare communities. Kerry Gumas, Questex President and Chief Executive Officer,…

READ MORE


Media Roundup — Coverage from 5th Digital Marketing for Medical Devices

DevicesMN-300x200With more than 140 industry marketers, sales professionals and thought leaders in attendance at the 5th Digital Marketing for Medical Devices conference, this three-day event was a resounding success. The speakers were insightful and engaging, and delegates returned to work armed with best practices and new strategies to try in their workplaces — but don’t just take our word for it. These recaps will give you a glimpse of what you may have missed if you were unable to come to this event.
Words of Wisdom from Prolifiq and App Data…

READ MORE


Colleagues, Coffee and Communications — A Roundup of the #ExLPRSummit Coverage

PR Summit recapWhen the 11th Annual Public Relations & Communications Summit took place in July, more than 150 PR and comm professionals joined ExL Pharma at Sanofi’s New Jersey headquarters to participate in one of our favorite conferences of the year. We love engaging with our audience and hearing their thoughts, and are excited to share coverage of the event through their eyes with you.
What Attendees Had to Say

On the Makovsky Health blog, Group Vice President Rob Murphy discussed the importance of meaningful connections and value-added interactions….

READ MORE


ExL Events’ December Conference Showcases Latest OTC Trends

Report: Rx to OTC switches drive growthAs highlighted by ExL Events’ Rx to OTC Summit Chairperson Steve Francesco of Francesco International, switches to OTC are on the rise in both volume and in generating sales. Indeed, as many as seven switches may be approved through 2016, and over the counter drug sales have increased with the recent switches of two high-profile allergy medications, Nexium 24HR and Nasacort Allergy 24HR.

In the coming years, switches will likely spread to medications that treat chronic diseases, a change that is sure to be a…

READ MORE


Page 1 of 212
live chat software